Agility Robotics to List as Wall Street's First Humanoid-Robot Bet

Agility Robotics became the first humanoid-focused company to list on a US exchange Thursday, closing its Nasdaq debut at $11.51 per share, up 2.2%, and immediately handing institutional investors the most transparent financial window yet into an industry that has absorbed billions of dollars in private capital without producing a profitable robot.

The Oregon-based company completed a merger with Churchill Capital Corp XI, a special-purpose acquisition company led by former Citigroup executive Michael Klein, valuing Agility's existing equity at approximately $2.5 billion . The deal gave Agility access to roughly $465 million in gross capital before expenses, including $100 million already received at the time of filing . Agility trades under the ticker AGLT on Nasdaq.

Agility CEO Peggy Johnson, who previously led Magic Leap and held senior roles at Microsoft and Qualcomm, framed the timing as a deliberate market positioning move. "There's something to be said for being first," Johnson told Business Insider. "We will be able to set many of the metrics, if you will, on what customers need in a humanoid."

For institutional investors evaluating the humanoid sector, Agility's public filings matter less as a company story and more as a sector price discovery event. For the first time, public markets can test a valuation thesis, examine unit economics, and compare the result against a roster of private peers that have so far escaped quarterly scrutiny entirely.

$1.8 Million in Revenue, $138.1 Million in Losses: The Gap Is Structural

The financials disclosed in Agility's merger filings are stark. The company generated $1.8 million in revenue last year while recording a net loss of $138.1 million . More than half of that revenue came from five robots purchased by a single investor . Agility lost $2.7 million on its sales before accounting for research and operating overhead .

The loss structure reveals two distinct components. Approximately $38 million of the $138.1 million net loss reflected non-cash charges tied to employee stock awards. The remaining $99.8 million was cash consumed by operations last year . At that burn rate, the $465 million gross capital raise equates to roughly four to five years of runway at current cash consumption, before the company scales manufacturing or accelerates headcount.

The company disclosed in SEC filings: "We expect to incur additional losses and higher operating expenses for the foreseeable future."

$99.8 million

cash used to run the business last year, against $1.8 million in revenue, a cash conversion ratio that no PE underwriter would accept from a mature business but that growth-stage hardware companies routinely defend by citing order backlog and manufacturing ramp trajectories.

Michelle Sun, a robotics analyst who authors the Substack Core Matter, identified the central constraint. "There's a lot of challenges when it comes to solving unit economics," Sun told Business Insider .

The $300 Million Order Book and What It Actually Requires

Agility's near-term commercial case rests on a single data point from its filing: more than $300 million in orders for 1,000 robots from one unnamed customer, contracted on a pay-to-use basis over three years . The implied per-unit contract value is approximately $300,000 per robot across the three-year term, or roughly $100,000 annually per unit.

Those orders carry conditions. Delivery depends on Agility meeting production deadlines and delivering robots with the specified feature set . The company is targeting first deliveries in the first half of 2027, with general availability by the end of that year .

Our view: a single-customer order concentration of this magnitude in a hardware business at pre-scale creates binary execution risk. If that customer delays acceptance, reduces scope, or invokes delivery clause protections, the financial narrative for 2027 collapses entirely. Investors buying AGLT today are underwriting a manufacturing ramp that does not yet exist and a customer relationship that remains undisclosed.

Agility has deployed its humanoid robot Digit across nine customer facilities, including sites operated by Amazon, Toyota, and logistics firm GXO . Its investor base includes Amazon, Foxconn, Nvidia, SoftBank, and venture firm DCVC . The Amazon relationship, as both investor and customer, adds a layer of strategic alignment but also raises questions about arm's length pricing on the revenue line. The company's filings note that more than half of its revenue last year came from robot purchases by one of its investors .

Valuation Table: Agility vs. Private Humanoid Peers

The valuation gap between Agility's $2.5 billion public market figure and its private-market competitors is not a rounding error. It is a structural feature of how public and private capital price identical technology risk.

George Chowdhury, principal analyst at ABI Research, identified the market's pricing logic directly. "This is a trend we're seeing, where companies with deployments who are actually shipping hardware today are valued by the market a lot lower than companies that are betting on this future," Chowdhury told Business Insider .

The implication for PE and growth equity portfolios holding positions in Figure AI or Apptronik is uncomfortable. Agility is the most commercially advanced humanoid company in the US by deployment count, with nine customer sites and a named client list including Amazon . If Agility clears at $2.5 billion with $300 million in conditional backlog, the private-market valuations of its pre-revenue competitors require scrutiny that quarterly LP reports do not currently provide.

The Regulatory Tailwind and China's 90% Share Problem

Agility's public debut arrives against a shifting regulatory backdrop that creates a structural advantage for US-based manufacturers. In July, the Federal Communications Commission banned new foreign-made advanced robotic devices, including humanoids, quadrupeds, and certain robot vacuums . Agility manufactures Digit at its Oregon factory .

Chinese robotics firms accounted for approximately 90% of humanoid robot shipments last year, according to data from research firm Omdia . Unitree, one of China's leading humanoid manufacturers, listed on the Shanghai Stock Exchange and carries a market value of approximately $40 billion .

The FCC restriction, if enforced broadly and sustained through procurement cycles, redirects addressable demand toward US manufacturers at the precise moment Agility is ramping Digit 5 production. Johnson framed it in competitive terms. "It's good for the US to show strength in this area," she told Business Insider .

The Plocamium view on this regulatory dynamic goes further: the FCC ban functions less as trade protection and more as a forced market share transfer. If humanoid adoption accelerates in US warehousing and logistics over the next three to five years, the addressable market defaults to a short list of domestic suppliers. Agility, as the only publicly traded US humanoid company, becomes the default reference asset for that trade, regardless of near-term losses.

The SPAC Structure and What Michael Klein's Involvement Signals

Agility's route to public markets through a SPAC merger with Churchill Capital Corp XI reflects both opportunism and pragmatism. SPAC volumes collapsed in 2022 as interest rates rose, but are drawing renewed interest as the broader IPO market recovers . Johnson said the company chose the SPAC structure specifically to access Michael Klein as a sponsor . Klein has a track record of taking technology-adjacent companies public, including Oklo, the nuclear power company backed by Sam Altman, and electric vehicle manufacturer Lucid .

The choice of Klein signals a deliberate attempt to frame Agility within the AI and clean-tech capital formation narrative, not simply as a robotics company. That framing matters for the investor base a company attracts at listing and in subsequent capital raises.

The Plocamium View

The market is pricing Agility as a hardware startup with a unit economics problem. That is accurate. What it is missing is that Agility's public listing is not primarily a financing event. It is a price discovery event for an entire asset class.

For every institutional investor sitting on a private position in Figure AI, Apptronik, or any of the dozens of humanoid startups that raised capital in 2024 and 2025 at valuations built on future market size projections, Agility's $2.5 billion clearing price is now the floor reference. Sun noted that Agility's listing would provide a reference point for how public markets value a humanoid company . That is an understatement.

The second-order effect is on LP portfolios: growth equity and venture funds that marked humanoid positions at multiples implied by the Figure AI $39 billion valuation now face a public comp that trades at a fraction of those levels, against the most commercially deployed humanoid in the US market. Mark-to-market conversations at the next quarterly cycle will be difficult.

The third-order play is in procurement. US defense, logistics, and manufacturing primes that have been evaluating humanoid pilots are now watching a public company with a known cost structure and customer list. That reduces negotiating asymmetry for buyers and accelerates commercial trials. The FCC restriction on foreign-made robots compounds this by limiting the competitive set.

The genuine risk is binary execution on the 1,000-unit Digit 5 order. If Agility misses the first-half 2027 delivery window, the stock re-rates toward the cash burn math and the narrative collapses. At $99.8 million in annual cash consumption and $465 million in gross proceeds, the financial buffer is real but not unlimited.

The Bottom Line

Agility Robotics' Nasdaq debut is the most important data point in humanoid robotics finance since the sector began attracting institutional capital. The company entered public markets with $1.8 million in revenue, a $138.1 million net loss, and a $2.5 billion valuation. The gap between that figure and the $39 billion ascribed to Figure AI by private markets is not a function of competitive differentiation. It is a function of accountability. Public markets require quarterly disclosure. Private markets do not.

The forward question is whether Agility delivers 1,000 Digit 5 units to its unnamed customer by mid-2027. If it does, the unit economics narrative shifts and every private humanoid valuation in a PE or venture portfolio gets a defensible upward revision. If it misses, the SPAC structure, the burn rate, and the customer concentration all become the story simultaneously. Investors who buy the thesis at $11.51 are placing a bet on a manufacturing ramp, not a product.

The FCC's restriction on foreign-made humanoids, combined with Chinese firms controlling 90% of current shipments, means the structural demand argument for US humanoid manufacturers is real and growing. The question is whether Agility can survive long enough to capture it.